Personal information

Activities

Works (10)

The burden of severe exacerbations, their relationship to clinical outcomes and the use of health resources in the Russian population of patients with chronic obstructive pulmonary disease: a subanalysis of the Russian population of EXACOS International Study

PULMONOLOGIYA
2024-05-15 | Journal article
Contributors: S. N. Avdeev; I. V. Leshchenko; G. V. Ignatova; V. N. Antonov; N. E. Kostina; E. U. Kochegarova; A. I. Aristov; N. V. Trushenko; S. Yu. Chikina; G. S. Nuralieva et al.
Source: check_circle
Crossref

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

Pharmacy & Pharmacology
2023-02-13 | Journal article
Contributors: L. A. Balykova; O. A. Radaeva; K. Ya. Zaslavskaya; P. A. Bely; V. F. Pavelkina; N. A. Pyataev; A. Yu. Ivanova; G. V. Rodoman; N. E. Kostina; V. B. Filimonov et al.
Source: check_circle
Crossref

Experience in the use of hyperbaric oxygen therapy in oxygen-dependent patients with severe forms of coronavirus infection

Bulletin of the Medical Institute of Continuing Education
2022 | Journal article
Contributors: O.Yu. EFREMOVA; A.A. ZAITSEV; O.V. ZOLOTUKHIN; N.E. KOSTINA; Yu.A. SHARAPOVA
Source: check_circle
Crossref

CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19

Pharmacy & Pharmacology
2022-12-15 | Journal article
Contributors: E. V. Tavlueva; E. V. Zernova; M. P. Kutepova; N. E. Kostina; V. S. Lesina; D. R. Mould; K. Ito; A. V. Zinchenko; A. N. Dolgorukova; M. V. Nikolskaya et al.
Source: check_circle
Crossref

Results of an open observational multicenter study of the effectiveness and tolerability of levodropropizine in comparison with standard antitussive therapy (real practice) in the treatment of patients with COVID-19

PULMONOLOGIYA
2022-08-16 | Journal article
Contributors: A. A. Zaicev; E. V. Bolotova; A. V. Dudnikova; L. V. Sнulzhenko; A. A. Vizel; N. E. Kostina; N. G. Nedashkovskaya
Source: check_circle
Crossref

A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR)

medRxiv
2021 | Other
EID:

2-s2.0-85106622007

Contributors: Patel, J.; Beishuizen, A.; Ruiz, X.B.; Boughanmi, H.; Cahn, A.; Criner, G.J.; Davy, K.; De-Miguel-Díez, J.; Fernandes, S.; François, B. et al.
Source: Self-asserted source
Natalia Kostina via Scopus - Elsevier

Comparative study of biosimilar Genolar® clinical efficacy on the randomized phase III study results,Сравнительное биоаналогичного рандомизированного изучение препарата клинического клинической Геноларисследования ® по эффективности результатам III фазы

Pulmonologiya
2021 | Journal article
EID:

2-s2.0-85099195666

Part of ISSN: 08690189
Contributors: Nenasheva, N.M.; Aver’yanov, A.V.; Il’ina, N.I.; Avdeev, S.N.; Osipova, G.L.; Rubanik, T.V.; Zorin, V.N.; Molotkov, A.O.; Kuzubova, N.A.; Kostina, N.E. et al.
Source: Self-asserted source
Natalia Kostina via Scopus - Elsevier

Management of cough in patients with chronic obstructive pulmonary disease: Results of the multicenter randomized placebo-controlled clinical trial

International Journal of COPD
2021 | Journal article
EID:

2-s2.0-85105841228

Part of ISSN: 11782005 11769106
Contributors: Avdeev, S.N.; Vizel, A.A.; Abrosimov, V.N.; Zaicev, A.A.; Ignatova, G.L.; Khamitov, R.F.; Mikhaylusova, M.P.; Shapovalova, J.S.; Pavlysh, E.F.; Trofimov, B.I. et al.
Source: Self-asserted source
Natalia Kostina via Scopus - Elsevier

Efficacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19,Эффективность и безопасность применения фавипиравира в комплексной терапии COVID-19 легкого и среднетяжелого течения

Infectious Diseases: News, Opinions, Training
2020 | Journal article
EID:

2-s2.0-85101237051

Part of ISSN: 26587394 23053496
Contributors: Ruzhentsova, T.A.; Chukhlyaev, P.V.; Khavkina, D.A.; Garbuzov, A.A.; Ploskireva, A.A.; Oseshnyuk, R.A.; Soluyanova, T.N.; Shestakova, I.V.; Vafin, A.Yu.; Dmitrikova, E.P. et al.
Source: Self-asserted source
Natalia Kostina via Scopus - Elsevier

Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19

SSRN
2020 | Other
EID:

2-s2.0-85110071577

Part of ISSN: 15565068
Contributors: Ruzhentsova, T.A.; Chukhliaev, P.V.; Khavkina, D.A.; Garbuzov, A.A.; Oseshnyuk, R.A.; Soluyanova, T.N.; Shestakova, I.V.; Vafin, A.Y.; Dmitrikova, E.P.; Mustafaev, D.M. et al.
Source: Self-asserted source
Natalia Kostina via Scopus - Elsevier